1819OTumor growth rate and lenvatinib efficacy in radioiodine-refractory differentiated thyroid cancer
Leboulleux, S, Lee, E K, Bastholt, L, Tahara, M, Wirth, L J, Sherman, S I, Robinson, B G, Teng, A, Joshi, P, Misir, S, Dutcus, C E, Tuttle, R M, Schlumberger, M JVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy302
Date:
October, 2018
File:
PDF, 92 KB
english, 2018